# Latus Bio: Company Profile

> Latus Bio is a Biotech Startup in Sahin’s portfolio. Latus Bio is developing curative AAV gene therapy products for CNS disorders.

Canonical: https://sahin.io/angel-investments/latus-bio
Last updated: 2026-11-15

## Facts

| | |
|---|---|
| Sector | [Biotech](https://sahin.io/angel-investments/biotech) |
| Sector | [Health](https://sahin.io/angel-investments/health) |
| Subsector | Gene Therapy, Therapeutics |
| Market | Biotech |
| Status | Active |
| Website | https://www.latus.bio/ |

Latus Bio is developing curative AAV gene therapy products for CNS disorders

## Investors named in public sources

- DCVC Bio (venture firm)
- BioAdvance (venture firm)
- 8VC (venture firm)
- Ben Franklin Technology Partners (investment firm)
- Gaingels (venture firm)
- Modi Ventures (investment firm)
- Samsung Ventures (corporate investor)
- Helen’s Pink Sky Foundation (other)
- KDB Silicon Valley (investment firm)

Full list with sources: https://sahin.io/angel-investments/latus-bio/angel-investors

## Related

- [Colossal](https://sahin.io/angel-investments/colossal)
- [Hologen](https://sahin.io/angel-investments/hologen)
- [Koniku](https://sahin.io/angel-investments/koniku)
- [Portfolio home](https://sahin.io/angel-investments/)
